We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights

18 hedge funds and large institutions have $4.17M invested in Bristol-Myers Squibb Rights in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0.02%0.02% (+0%)

10% less funds holding

Funds holding: 2018 (-2)

23% less capital invested

Capital invested by funds: $5.44M → $4.17M (-$1.27M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
Increased
3
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CELG.RT Hedge Fund Activity: Q2 2024 in Review

18 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2024, worth a combined $4.17M — down 23% from $5.44M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CELG.RT and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was Susquehanna International Group, adding an estimated $2.34K. The largest seller was CAPTRUST Financial Advisors, exiting entirely with an estimated $1.13K sold.

  • 18 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2024, down from 20 in Q1 2024.
  • Funds reported $4.17M of Bristol-Myers Squibb Rights stock for Q2 2024, down 23% quarter-over-quarter.
  • 0 funds opened new Bristol-Myers Squibb Rights positions in Q2 2024 and 2 closed out, a net change of -2 holders.
  • The largest Bristol-Myers Squibb Rights buyer in Q2 2024 was Susquehanna International Group, an estimated $2.34K added.
  • The largest Bristol-Myers Squibb Rights seller in Q2 2024 was CAPTRUST Financial Advisors, an estimated $1.13K sold.

Based on aggregated 13F filings for Q2 2024.